Aurora appoints Gail Hanson as SVP, CFO
MILWAUKEE — Aurora Health Care has appointed a Wisconsin state official as its SVP and CFO.
The nonprofit health system, which runs Aurora Health Care Pharmacy in Wisconsin, announced the appointment of Gail Hanson to the two positions, replacing David Eager, who will continue with Aurora’s finance group under Hanson’s leadership.
Hanson previously served as deputy executive director of the State of Wisconsin Investment Board since 2004, being in charge of accounting, governance and general management functions. The SWIB manages the assets of the Wisconsin Retirement System, the State Investment Fund and other state trust funds, with a total of more than $78 billion in assets as of 2009, according to the organization’s website.
“We in health care are facing a time of many complex financial challenges and opportunities brought about by federal and state reform, the down economy, the competitive landscape and declining reimbursement,” Aurora Health Care president and CEO Nick Turkal said. “Gail’s strong record of financial leadership in the public and private sectors and her strategic capabilities will put Aurora in a position to capitalize on the opportunities ahead of us.”
From 1999 to 2004, Hanson was SVP, treasurer and CFO for Cobalt, a Milwaukee-based health insurer that grew out of Blue Cross Blue Shield United of Wisconsin and since has changed its name to Anthem Blue Cross Blue Shield.
Kapvay designed to treat ADHD
FLORHAM PARK, N.J. — Drug maker Shionogi has launched a new medication for attention deficit hyperactivity disorder, the company said Monday.
Shionogi announced the launch of Kapvay (clonidine hydrochloride), an extended-release drug for treating ADHD in children and adolescents. The company said the drug was the only ADHD treatment approved as an add-on to stimulant medications, though it can be used alone as well.
“Shionogi is extremely proud to bring Kapvay to market in the United States,” Shionogi chief medical officer Donald Manning said. “The extended-release version of clonidine hydrochloride found in Kapvay offers an exciting new treatment option for children and adolescents with ADHD who are not experiencing adequate symptom relief from stimulants alone.”
PakSense introduces BIOmed Label
BOISE, Idaho — PakSense has launched a small device for monitoring the temperatures of medicines, the company said Monday.
PakSense said its BIOmed Label is about the size of a sugar packet and can be used to digitally monitor the temperatures of pharmaceuticals, biologics and vaccines during storage and distribution.
The company said the monitors are different from other similar devices because they read the temperature off the surface of the object to which they’re attached, allowing a closer approximation of the product’s temperature versus general ambient readings. Other features include LEDs that flash if a specified temperature range is breached and the ability to download and graph temperature readings on a computer. The PakSense Wireless Reader will download temperature data within a 300-ft line of sight, or 60 ft if an object is in the way.
“PakSense has brought a truly innovative temperature-monitoring product to the life sciences space,” PakSense CEO David Light said. “Our new class of recorder is fundamentally changing the way temperature monitoring is performed and is helping quality assurance teams extend their reach into virtually all areas of the supply chain.”